Physics of Protein Aggregation in Normal and Accelerated Brain Aging
BioEssays · 2025
DOI: 10.1002/bies.70030 ↗At a glance
Übersichtsarbeit in BioEssays, 2025. Written by Alberto J Espay and 9 co-authors. Institution: James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinn…. Major MEDLINE topics: Aging, Brain, Protein Aggregates, Protein Aggregation, Pathological. Cited 8 times so far (Crossref); 160 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Protein aggregation is a normal response to age‐related exposures. According to the thermodynamic hypothesis of protein folding, soluble proteins precipitate into amyloids (pathology) under supersaturated conditions through a process similar to crystallization. This soluble‐to‐insoluble phase transition occurs via nucleation and may be catalyzed by ectopic surfaces such as lipid nanoparticles, microbes, or chemical pollutants. The increasing prevalence of these exposures with age correlates with the rising incidence of pathology over the lifespan. However, the formation of amyloid fibrils does not inherently cause neurodegeneration. Neurodegeneration emerges when the levels of functional monomeric proteins, from which amyloids form, fall below a critical threshold. The preservation of monomeric proteins may explain neurological resilience, regardless of the extent of amyloid deposition. This biophysical framework challenges the traditional clinicopathological view that considers amyloids intrinsically toxic, despite the absence of a known mechanism of toxicity. Instead, it suggests that chronic exposures driving persistent nucleation consume monomeric proteins as they aggregate. In normal aging, replacement matches loss; in accelerated aging, it does not. A biophysical approach to neurodegenerative diseases has important therapeutic implications, refocusing treatment strategies from removing pathology to restoring monomeric protein homeostasis above the threshold needed to sustain normal brain function.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, Ohio, USA.
- Section of Neurology, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Neurogenetics Research Centre, IRCCS Mondino Foundation, Pavia, Italy.
- Department of Radiology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Center for functionally integrative neuroscience, Institute for Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID profiles: Alberto J Espay, Alberto Imarisio
Cite
APA
Espay, A. J., Sturchio, A., Imarisio, A., Hill, E. J., Williamson, B., Montemagno, K., Hoffmann, C., Roy, H. L., Milovanovic, D., & Manfredsson, F. P. (2025). Physics of Protein Aggregation in Normal and Accelerated Brain Aging. BioEssays. https://doi.org/10.1002/bies.70030
Vancouver
Espay AJ, Sturchio A, Imarisio A, Hill EJ, Williamson B, Montemagno K, et al. Physics of Protein Aggregation in Normal and Accelerated Brain Aging. BioEssays. 2025. doi:10.1002/bies.70030
BibTeX
@article{Espay2025,
author = {Espay, Alberto J and Sturchio, Andrea and Imarisio, Alberto and Hill, Emily J and Williamson, Brady and Montemagno, Kora and Hoffmann, Christian and Roy, Hugo Le and Milovanovic, Dragomir and Manfredsson, Fredric P},
title = {Physics of Protein Aggregation in Normal and Accelerated Brain Aging},
journal = {BioEssays},
year = {2025},
doi = {10.1002/bies.70030}
}
EUVIMED